Orally administered prednisolone decreases plasma arginine vasopressin and serum copeptin concentrations in healthy dogs

Abstract Background The pathophysiology of polyuria and polydipsia secondary to exogenous glucocorticoid excess is incompletely understood. Objective Investigate plasma AVP (pAVP) and serum CoP (sCoP) concentrations in healthy dogs before, during, and after abrupt discontinuation of a long‐term cour...

Full description

Saved in:
Bibliographic Details
Main Authors: Mathieu Victor Paulin, Dorsa Mehrabanpour, Suraj Unniappan, Elisabeth C. R. Snead
Format: Article
Language:English
Published: Wiley 2025-01-01
Series:Journal of Veterinary Internal Medicine
Subjects:
Online Access:https://doi.org/10.1111/jvim.17304
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832584126729814016
author Mathieu Victor Paulin
Dorsa Mehrabanpour
Suraj Unniappan
Elisabeth C. R. Snead
author_facet Mathieu Victor Paulin
Dorsa Mehrabanpour
Suraj Unniappan
Elisabeth C. R. Snead
author_sort Mathieu Victor Paulin
collection DOAJ
description Abstract Background The pathophysiology of polyuria and polydipsia secondary to exogenous glucocorticoid excess is incompletely understood. Objective Investigate plasma AVP (pAVP) and serum CoP (sCoP) concentrations in healthy dogs before, during, and after abrupt discontinuation of a long‐term course of orally administered prednisolone. Animals Eight healthy neutered young adult research Beagles. Methods In our prospective longitudinal study, Beagles were treated with a placebo PO q24h for 15 days (baseline), followed by a 35‐day course of prednisolone (2.35‐2.75 mg/kg PO q24h) and then abrupt discontinuation of prednisolone. Serial pAVP and sCoP concentrations, urine specific gravity (USG) and calculated plasma osmolality (pOsmcalculated) were determined during placebo and prednisolone administration, and up to 4 weeks after prednisolone discontinuation. Paired plasma samples for pAVP measurement were obtained in EDTA tubes with (pAVPP800) and without (pAVPEDTA) a proprietary combination of protease, esterase, and dipeptidyl peptidase‐IV inhibitors (BD Biosciences P800). Results Mean pAVPP800 and sCoP concentrations were significantly lower at the end of the prednisolone course (25.8 ± 8.1 pg/mL and 166 pg/mL, range, 131‐223) vs baseline (34.1 ± 5.4 pg/mL and 243 pg/mL, range, 157‐336; P = .02, P = .02, respectively). Correlations between pAVPP800 and sCoP (r = .77, P = .001) and pAVPP800 and USG (r = .61, P = .02) were positive, despite no correlation between pAVPP800 and pOsmcalculated, sCoP and pOsmcalculated, and sCoP and USG. On paired samples, mean pAVPEDTA was significantly lower (5.0 ± 2.5 pg/mL) than mean pAVPP800 (34.1 ± 5.4 pg/mL; P < .0001). Conclusions and Clinical Importance Orally administered prednisolone led to markedly decreased plasma AVP and serum CoP concentrations despite increased calculated plasma osmolality and stable systolic blood pressure.
format Article
id doaj-art-091bb31aa4594f03a19edc5ad3549d5c
institution Kabale University
issn 0891-6640
1939-1676
language English
publishDate 2025-01-01
publisher Wiley
record_format Article
series Journal of Veterinary Internal Medicine
spelling doaj-art-091bb31aa4594f03a19edc5ad3549d5c2025-01-27T15:22:41ZengWileyJournal of Veterinary Internal Medicine0891-66401939-16762025-01-01391n/an/a10.1111/jvim.17304Orally administered prednisolone decreases plasma arginine vasopressin and serum copeptin concentrations in healthy dogsMathieu Victor Paulin0Dorsa Mehrabanpour1Suraj Unniappan2Elisabeth C. R. Snead3Department of Small Animal Clinical Sciences, Western College of Veterinary Medicine University of Saskatchewan Saskatoon Saskatchewan CanadaDepartment of Veterinary Biomedical Sciences, Western College of Veterinary Medicine University of Saskatchewan Saskatoon Saskatchewan CanadaDepartment of Veterinary Biomedical Sciences, Western College of Veterinary Medicine University of Saskatchewan Saskatoon Saskatchewan CanadaDepartment of Small Animal Clinical Sciences, Western College of Veterinary Medicine University of Saskatchewan Saskatoon Saskatchewan CanadaAbstract Background The pathophysiology of polyuria and polydipsia secondary to exogenous glucocorticoid excess is incompletely understood. Objective Investigate plasma AVP (pAVP) and serum CoP (sCoP) concentrations in healthy dogs before, during, and after abrupt discontinuation of a long‐term course of orally administered prednisolone. Animals Eight healthy neutered young adult research Beagles. Methods In our prospective longitudinal study, Beagles were treated with a placebo PO q24h for 15 days (baseline), followed by a 35‐day course of prednisolone (2.35‐2.75 mg/kg PO q24h) and then abrupt discontinuation of prednisolone. Serial pAVP and sCoP concentrations, urine specific gravity (USG) and calculated plasma osmolality (pOsmcalculated) were determined during placebo and prednisolone administration, and up to 4 weeks after prednisolone discontinuation. Paired plasma samples for pAVP measurement were obtained in EDTA tubes with (pAVPP800) and without (pAVPEDTA) a proprietary combination of protease, esterase, and dipeptidyl peptidase‐IV inhibitors (BD Biosciences P800). Results Mean pAVPP800 and sCoP concentrations were significantly lower at the end of the prednisolone course (25.8 ± 8.1 pg/mL and 166 pg/mL, range, 131‐223) vs baseline (34.1 ± 5.4 pg/mL and 243 pg/mL, range, 157‐336; P = .02, P = .02, respectively). Correlations between pAVPP800 and sCoP (r = .77, P = .001) and pAVPP800 and USG (r = .61, P = .02) were positive, despite no correlation between pAVPP800 and pOsmcalculated, sCoP and pOsmcalculated, and sCoP and USG. On paired samples, mean pAVPEDTA was significantly lower (5.0 ± 2.5 pg/mL) than mean pAVPP800 (34.1 ± 5.4 pg/mL; P < .0001). Conclusions and Clinical Importance Orally administered prednisolone led to markedly decreased plasma AVP and serum CoP concentrations despite increased calculated plasma osmolality and stable systolic blood pressure.https://doi.org/10.1111/jvim.17304ADHanti‐diuretic hormoneAVPglucocorticoidsprotease inhibitor
spellingShingle Mathieu Victor Paulin
Dorsa Mehrabanpour
Suraj Unniappan
Elisabeth C. R. Snead
Orally administered prednisolone decreases plasma arginine vasopressin and serum copeptin concentrations in healthy dogs
Journal of Veterinary Internal Medicine
ADH
anti‐diuretic hormone
AVP
glucocorticoids
protease inhibitor
title Orally administered prednisolone decreases plasma arginine vasopressin and serum copeptin concentrations in healthy dogs
title_full Orally administered prednisolone decreases plasma arginine vasopressin and serum copeptin concentrations in healthy dogs
title_fullStr Orally administered prednisolone decreases plasma arginine vasopressin and serum copeptin concentrations in healthy dogs
title_full_unstemmed Orally administered prednisolone decreases plasma arginine vasopressin and serum copeptin concentrations in healthy dogs
title_short Orally administered prednisolone decreases plasma arginine vasopressin and serum copeptin concentrations in healthy dogs
title_sort orally administered prednisolone decreases plasma arginine vasopressin and serum copeptin concentrations in healthy dogs
topic ADH
anti‐diuretic hormone
AVP
glucocorticoids
protease inhibitor
url https://doi.org/10.1111/jvim.17304
work_keys_str_mv AT mathieuvictorpaulin orallyadministeredprednisolonedecreasesplasmaargininevasopressinandserumcopeptinconcentrationsinhealthydogs
AT dorsamehrabanpour orallyadministeredprednisolonedecreasesplasmaargininevasopressinandserumcopeptinconcentrationsinhealthydogs
AT surajunniappan orallyadministeredprednisolonedecreasesplasmaargininevasopressinandserumcopeptinconcentrationsinhealthydogs
AT elisabethcrsnead orallyadministeredprednisolonedecreasesplasmaargininevasopressinandserumcopeptinconcentrationsinhealthydogs